Biosynthesis of Three Chalcone β-D-glucosides by Glycosyltransferase from Bacillus subtilis ATCC 6633
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chalcones exhibit multiple biological activities. Various studies have attempted to modify the structure of chalcones with a special focus on the addition of substituents to the benzene rings. However, these chemical modifications did not improve the water solubility and bioavailability of chalcones. Glycosylation can markedly affect the physical and chemical properties of hydrophobic compounds. Here, we evaluated the ability of a highly promiscuous glycosyltransferase (GT) BsGT1 from Bacillus subtilis ATCC 6633 to biosynthesize chalcone glucosides. Purified BsGT1 catalyzed the conversion of 4'-hydroxychalcone (compound 1), 4'-hydroxy-4-methylchalcone (compound 2), and 4-hydroxy-4'-methoxychalcone (compound 3), into chalcone 4'-O-β-D-glucoside (compound 1a), 4-methylchalcone 4'-O-β-D-glucoside (compound 2a), and 4'- methoxychalcone 4-O-β-D-glucoside (compound 3a), respectively. To avoid the addition of expensive uridine diphosphate glucose (UDP-Glc), a whole-cell biotransformation system was employed to provide a natural intracellular environment for in situ co-factor regeneration. The yields of compounds 1a, 2a, and 3a were as high as 90.38%, 100% and 74.79%, respectively. The successful co-expression of BsGT1 with phosphoglucomutase (PGM) and UDP-Glc pyrophosphorylase (GalU), which are involved in the biosynthetic pathway of UDP-Glc, further improved the conversion rates of chalcones (the yields of compounds 1a and 3a increased by approximately 10%). In conclusion, we demonstrated an effective whole-cell biocatalytic system for the enzymatic biosynthesis of chalcone β-D-glucoside derivatives.
Abstract
Chalcones exhibit multiple biological activities. Various studies have attempted to modify the structure of chalcones with a special focus on the addition of substituents to the benzene rings. However, these chemical modifications did not improve the water solubility and bioavailability of chalcones. Glycosylation can markedly affect the physical and chemical properties of hydrophobic compounds. Here, we evaluated the ability of a highly promiscuous glycosyltransferase (GT) BsGT1 from Bacillus subtilis ATCC 6633 to biosynthesize chalcone glucosides. Purified BsGT1 catalyzed the conversion of 4'-hydroxychalcone (compound 1), 4'-hydroxy-4-methylchalcone (compound 2), and 4-hydroxy-4'-methoxychalcone (compound 3), into chalcone 4'-O-β-D-glucoside (compound 1a), 4-methylchalcone 4'-O-β-D-glucoside (compound 2a), and 4'- methoxychalcone 4-O-β-D-glucoside (compound 3a), respectively. To avoid the addition of expensive uridine diphosphate glucose (UDP-Glc), a whole-cell biotransformation system was employed to provide a natural intracellular environment for in situ co-factor regeneration. The yields of compounds 1a, 2a, and 3a were as high as 90.38%, 100% and 74.79%, respectively. The successful co-expression of BsGT1 with phosphoglucomutase (PGM) and UDP-Glc pyrophosphorylase (GalU), which are involved in the biosynthetic pathway of UDP-Glc, further improved the conversion rates of chalcones (the yields of compounds 1a and 3a increased by approximately 10%). In conclusion, we demonstrated an effective whole-cell biocatalytic system for the enzymatic biosynthesis of chalcone β-D-glucoside derivatives.
참고문헌 (15)
- Orlikova B, "Dietary chalcones with chemopreventive and chemotherapeutic potential", Genes Nutr, 6, pp.125~147 (2011)
- Al-Mamary M, "Synthesis and biological activities of some chalcone derivatives", Int. J. Chem. Pharm. Sci, 5, pp.8~ (2014)
- Ma Y, "Metabolism of phenolic compounds in LPS-stimulated Raw264.7Cells can impact their anti-inflammatory efficacy: Indication of hesperetin", J. Agric. Food Chem, 66, pp.6042~6052 (2018)
- Sangpheak K, "Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines", J. Enzyme Inhib. Med. Chem, 34, pp.134~143 (2019)
- Hofer B, "Recent developments in the enzymatic O-glycosylation of flavonoids", Appl. Microbiol. Biotechnol, 100, pp.4269~4281 (2016)
- Pinho-Ribeiro FA, "Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice : Role of TRPV1, oxidative stress, cytokines and NF-κB", Chem. Biol. Interact, 228, pp.88~99 (2015)
- Manna T, "Anti-cancer potential of novel glycosylated 1, 4-substituted triazolylchalcone derivatives", Bioorg. Med. Chem. Lett, 29, pp.126615~ (2019)
- Xiao J, "Advances in the biotechnological glycosylation of valuable flavonoids", Biotechnol. Adv, 32, pp.1145~1156 (2014)
- Cheng Y, "Enzymecatalyzed glycosylation of curcumin and its analogues by glycosyltransferases from Bacillus subtilis ATCC 6633", Catalysts, 9, pp.734~ (2019)
- Mao Z, "Engineering the E. coli UDP-Glucose synthesis pathway for oligosaccharide synthesis", Biotechnol. Prog, 22, pp.369~374 (2006)
- Gomes MN, "Chalcone derivatives: Promising starting points for drug design", Molecules, 22, pp.1210~ (2017)
- Lowery JJ, "Glycosylation improves the central effects of DAMGO", Chem. Biol. Drug Des, 69, pp.41~47 (2007)
- Pandey RP, "Two Trifunctional Leloir Glycosyltransferases as biocatalysts for natural products glycodiversification", Org. Lett, 21, pp.8058~8064 (2019)
- Dai L, "Exploiting the aglycon promiscuity of glycosyltransferase Bs-YjiC from Bacillus subtilis and its application in synthesis of glycosides", J. Biotechnol, 248, pp.69~76 (2017)
- Yan Y, "High-yield anthocyanin biosynthesis in engineered Escherichia coli", Biotechnol. Bioeng, 100, pp.126~140 (2008)